SCFAs, primarily butyrate, propionate and acetate, can stimulate the release of the anorexigenic peptides including Peptide YY (PYY), amylin and Glucagon-like peptide 1 (GLP-1) and inhibit obesity caused by a high-fat diet. Here, PYY is linked to obesity disorder.